EMTEL Śliwa spółka komandytowa

EMTEL Śliwa produces a range of reusable and single-use medical devices primarily focused on patient monitoring and resuscitation. Their portfolio includes non-invasive blood pressure (NIBP) cuffs, defibrillators (such as the DefiMax Plus and DefiMax mobile), ECG leadwires (including 3-, 4-, and 10-wire sets), pulse oximetry extension cables, intra-blood pressure (IBP) double cables, and patient monitoring devices like the FX 3000MD series with LCD screens. These devices are designed for clinical use in monitoring vital signs and supporting emergency resuscitation.

EMTEL Śliwa spółka komandytowa is based in Poland. The company specializes in manufacturing medical devices for patient monitoring and resuscitation, with its operations and production facilities located within the country.

EMTEL Śliwa’s medical devices are registered in the euDAMED database, which is the European Union’s central registry for medical devices. This registry is used to track and provide transparency on devices authorized under EU Medical Device Regulations.

EMTEL Śliwa’s devices fall under Class I or Class IIb classifications according to the EU Medical Device Regulations. The classification depends on factors like the device’s intended use, risk level, and interaction with the body. For example, reusable NIBP cuffs are typically Class I, while defibrillators (like the DefiMax series) are often Class IIb due to their higher risk and critical role in emergency care.

Yes, EMTEL Śliwa’s devices serve dual purposes in clinical settings. Their patient monitoring devices (e.g., FX 3000MD series) continuously track vital signs like ECG, blood pressure, and SpO2, while their defibrillators (e.g., DefiMax Plus and DefiMax mobile) are designed for emergency resuscitation to restore normal heart rhythms. This dual functionality aligns with their core focus on monitoring biological parameters and resuscitation equipment.